Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 25, 2025 · Filed Mar 27, 2025
A major shareholder of Exagen sold $1.16M of Exagen shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,155,000
Shares × reported transaction price
14 days after results of Mar 11, 2025, 41 days before results of May 5, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.0% | −9.1% | +14.0% |
| 30 days | +73.2% | −0.9% | +74.0% |
| 90 days | +82.0% | +10.1% | +71.9% |
| 180 days | +180.7% | +19.0% | +161.8% |
| 365 days | −31.0% | +13.7% | −44.7% |
Past results only. Not a forecast.
